India Bladder Cancer Market to Reach $278.0 Million by 2035 Fueled by AI and Advanced Diagnostics

India bladder cancer market was valued at $153.1 million in 2025 and is projected to reach $278.0 million by 2035, growing at a CAGR of 6.2% during the forecast period (2026–2035). India’s bladder cancer market is witnessing steady transformation, supported by advancements in diagnostic technologies, treatment protocols, and digital healthcare integration. The increasing adoption of AI-Precision Oncology Centres represents an important structural shift in cancer care delivery across the country. These centres utilize AI enabled clinical decision support systems to assist oncologists in interpreting complex clinical data and identifying personalized treatment strategies within defined timelines. For instance, in January 2024, Apollo Cancer Centres launched an AI-Precision Oncology Centre at its Bengaluru facility, described as India’s first dedicated centre integrating AI into oncology care pathways. The centre is designed to support diagnosis, risk assessment, treatment planning, and monitoring by using AI-based tools to analyze genomic, clinical, and pathological data, generate clinical alerts, and identify patients eligible for targeted therapies and immunotherapy.

Browse the full report description of “India Bladder Cancer Market Size, Share & Trends Analysis Report by Cancer Type (Transitional Cell Bladder Cancer/ Urothelial Carcinoma, Squamous Cell Bladder Cancer, Adenocarcinoma, and Other Rare Types) By Diagnosis Method (Cystoscopy, Biopsy, Urinalysis, Urine Cytology, Intravenous Pyelogram (IVP), and Other) By Therapy (Chemotherapy, Immunotherapy, Radiation Therapy, Surgery, and Other), 2026–2035)” at https://www.omrglobal.com/industry-reports/india-bladder-cancer-market

AI-driven diagnostic tools are being incorporated to support earlier and more accurate detection of malignancies, which may contribute to improved patient outcomes and survival rates. Additionally, conversational AI platforms are being deployed to provide structured education to patients and caregivers, addressing common questions related to diagnosis, treatment pathways, and post-therapy care. Such systems also facilitate connections to counselling services and support groups, improving overall care coordination. The integration of these digital and precision oncology capabilities is strengthening institutional capacity and contributing to the long-term growth trajectory of the Indian oncology market.

Recent Institutional Developments Strengthening India’s Oncology Infrastructure

• In September 2025, Lilavati Hospital announced the establishment of a 300-bed Cancer Care Institute in Mumbai, aimed at expanding access to oncology services with the use of advanced technologies, including AI-based diagnostic tools for early detection and treatment planning. The facility will provide individualized cancer care and is expected to create employment opportunities across clinical and research roles.

• In September 2025, the Ministry of Ayush inaugurated the Integrative Oncology Research and Care Centre (IORCC) at the All India Institute of Ayurveda (AIIA) in Dhargal on the occasion of the 10th National Ayurveda Day. The centre is designed to integrate Ayurveda, Yoga, physiotherapy, diet therapy, Panchakarma and modern oncology services to provide rehabilitation-focused care for cancer patients under one roof. According to the Ministry, the facility will also function as a research and training hub aimed at developing evidence-informed integrative oncology protocols aligned with national health policy objectives.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Cancer Type
  • Diagnosis Method
  • Therapy
• Competitive Landscape - Astellas Pharma India Pvt. Ltd., Bristol-Myers Squibb India Pvt. Ltd., MSD Pharmaceuticals Pvt. Ltd., Pfizer India Pvt. Ltd. and Roche Products (India) Pvt. Ltd., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

India Bladder Cancer Market Report Segment

Cancer Type 

• Transitional Cell Bladder Cancer/Urothelial Carcinoma
• Squamous Cell Bladder Cancer
• Adenocarcinoma
• Others

Diagnosis Method

• Cystoscopy
• Biopsy
• Urinalysis
• Urine Cytology
• Intravenous Pyelogram (IVP)
• Others

By Therapy

• Surgery
• Chemotherapy
• Immunotherapy
• Radiation Therapy
• Others

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/india-bladder-cancer-market